These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 26338254)
1. Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer. Brisuda A; Pazourkova E; Soukup V; Horinek A; Hrbáček J; Capoun O; Svobodova I; Pospisilova S; Korabecna M; Mares J; Hanuš T; Babjuk M Urol Int; 2016; 96(1):25-31. PubMed ID: 26338254 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria. Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Kang HW; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ Urol Oncol; 2019 Jan; 37(1):86-96. PubMed ID: 30446454 [TBL] [Abstract][Full Text] [Related]
3. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial. Witjes JA; Morote J; Cornel EB; Gakis G; van Valenberg FJP; Lozano F; Sternberg IA; Willemsen E; Hegemann ML; Paitan Y; Leibovitch I Eur Urol Oncol; 2018 Sep; 1(4):307-313. PubMed ID: 31100252 [TBL] [Abstract][Full Text] [Related]
4. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer. Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis. Zancan M; Galdi F; Di Tonno F; Mazzariol C; Orlando C; Malentacchi F; Agostini M; Maran M; Del Bianco P; Fabricio AS; Murer B; Pianon C; Gion M Int J Biol Markers; 2009; 24(3):147-55. PubMed ID: 19787625 [TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer. de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037 [TBL] [Abstract][Full Text] [Related]
7. Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data. Casadio V; Calistri D; Tebaldi M; Bravaccini S; Gunelli R; Martorana G; Bertaccini A; Serra L; Scarpi E; Amadori D; Silvestrini R; Zoli W Urol Oncol; 2013 Nov; 31(8):1744-50. PubMed ID: 23141783 [TBL] [Abstract][Full Text] [Related]
8. New method to preserve the original proportion and integrity of urinary cell-free DNA. Li P; Ning J; Luo X; Du H; Zhang Q; Zhou G; Du Q; Ou Z; Wang L; Wang Y J Clin Lab Anal; 2019 Feb; 33(2):e22668. PubMed ID: 30175467 [TBL] [Abstract][Full Text] [Related]
9. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer. Fantony JJ; Abern MR; Gopalakrishna A; Owusu R; Jack Tay K; Lance RS; Inman BA Urol Oncol; 2015 Sep; 33(9):387.e1-6. PubMed ID: 26027762 [TBL] [Abstract][Full Text] [Related]
10. Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study. Ribal MJ; Mengual L; Lozano JJ; Ingelmo-Torres M; Palou J; Rodríguez-Faba O; Witjes JA; Van der Heijden AG; Medina R; Conde JM; Marberger M; Schmidbauer J; Fernández PL; Alcaraz A Eur J Cancer; 2016 Feb; 54():131-138. PubMed ID: 26761785 [TBL] [Abstract][Full Text] [Related]
11. [The role of telomerase activity in non-invasive diagnostics of bladder cancer]. Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer. Trenti E; Pycha S; Mian C; Schwienbacher C; Hanspeter E; Kafka M; Spedicato GA; Vjaters E; Degener S; Pycha A; D'Elia C Cancer Cytopathol; 2020 May; 128(5):341-347. PubMed ID: 31977131 [TBL] [Abstract][Full Text] [Related]
13. Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer. Xu Y; Kim YH; Jeong P; Piao XM; Byun YJ; Seo SP; Kang HW; Kim WT; Lee JY; Ryu DH; Choi JW; Kim IY; Moon SK; Choi YH; Yun SJ; Kim WJ Clin Genitourin Cancer; 2019 Jun; 17(3):e704-e711. PubMed ID: 31088707 [TBL] [Abstract][Full Text] [Related]
14. Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer. Ren S; Ren XD; Guo LF; Qu XM; Shang MY; Dai XT; Huang Q J Clin Lab Anal; 2020 Aug; 34(8):e23321. PubMed ID: 32281142 [TBL] [Abstract][Full Text] [Related]
15. Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma. Soukup V; Kalousová M; Capoun O; Sobotka R; Breyl Z; Pešl M; Zima T; Hanuš T Urol Int; 2015; 95(1):56-64. PubMed ID: 25662337 [TBL] [Abstract][Full Text] [Related]
16. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method. Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703 [TBL] [Abstract][Full Text] [Related]
17. Analysis of urine cell-free DNA in bladder cancer diagnosis by emerging bioactive technologies and materials. Huang FF; Di XF; Bai MH Front Bioeng Biotechnol; 2024; 12():1458362. PubMed ID: 39295845 [TBL] [Abstract][Full Text] [Related]
18. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection. Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682 [TBL] [Abstract][Full Text] [Related]
19. Urinary mRNA biomarker panel for the detection of urothelial carcinoma. Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851 [TBL] [Abstract][Full Text] [Related]
20. A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer. Huang S; Kou L; Furuya H; Yu C; Goodison S; Kattan MW; Garmire L; Rosser CJ Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1361-6. PubMed ID: 27383773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]